LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 79.34 | 84.90 | 227 | 9051 | 0.0251 | 0.1572 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 79.34 | 84.90 | 6719 | 9051 | 0.7423 | 0.9135 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 79.34 | 84.90 | 357 | 9051 | 0.0394 | 0.2377 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 79.34 | 84.90 | 7904 | 9051 | 0.8732 | 0.9602 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.05 | 84.90 | 232 | 8863 | 0.0262 | 0.1617 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.05 | 84.90 | 6830 | 8863 | 0.7705 | 0.9238 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.05 | 84.90 | 384 | 8863 | 0.0433 | 0.2524 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 81.05 | 84.90 | 8116 | 8863 | 0.9156 | 0.9739 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.75 | 84.90 | 212 | 8621 | 0.0246 | 0.1472 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.75 | 84.90 | 7033 | 8621 | 0.8158 | 0.9398 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.75 | 84.90 | 367 | 8621 | 0.0426 | 0.2456 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 82.75 | 84.90 | 8249 | 8621 | 0.9568 | 0.9868 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.45 | 84.90 | 179 | 8254 | 0.0217 | 0.1196 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.45 | 84.90 | 7110 | 8254 | 0.8613 | 0.9553 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.45 | 84.90 | 300 | 8254 | 0.0363 | 0.2107 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 84.45 | 84.90 | 8378 | 8254 | 1.0149 | 1.0045 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 86.16 | 84.90 | 230 | 8141 | 0.0282 | 0.1634 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 86.16 | 84.90 | 7319 | 8141 | 0.8989 | 0.9679 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 86.16 | 84.90 | 396 | 8141 | 0.0486 | 0.2635 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 86.16 | 84.90 | 8541 | 8141 | 1.0490 | 1.0146 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 84.90 | 215 | 7680 | 0.0280 | 0.1537 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 84.90 | 7455 | 7680 | 0.9707 | 0.9909 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 84.90 | 372 | 7680 | 0.0484 | 0.2552 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 87.86 | 84.90 | 8731 | 7680 | 1.1368 | 1.0398 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 89.57 | 84.90 | 244 | 7494 | 0.0326 | 0.1774 | MN20160318_Q02 | E17 |